Oric Pharmaceuticals Inc. ORIC
Super Investor & Insider
1
Fondi che lo detengono
#830
Rank consenso
1.4%
% dei portafogli
$73.8M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Viking Global Investors · Viking Global Investors | 0.21% | Reduce 11.38% | 5,824,533 | $73.8M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Oric Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing therapies that address mechanisms of therapeutic resistance in cancer. The company targets innate, acquired, and bypass resistance to overcome limitations in existing cancer treatments, with a particular emphas…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees104
TickerORIC
Statistics
Market Cap$893.1M
Revenue (TTM)—
Net Income-$129.5M
Net Margin—
EPS$-1.47
P/E-5.63
P/S—
P/B1.95
EV/EBITDA-3.40
ROE-42.6%
Dividend Yield—
Price$8.63
Data: Twelve Data · Revenue = mcap / P/S